Trending News

Sanofi and Regeneron's Dupixent scores 3rd FDA app

Sanofi and Regeneron’s Dupixent has been charging ahead since its initial approval in moderate-to-se
Read More

Merck, Pfizer keep high-flying vaccine sales intac

Merck and Pfizer faced uncertainty on big-selling vaccines going into this week’s meeting of the Adv
Read More

U.S. representatives to Gilead: Did your donation

In May, Gilead pledged to donate 2.4 million bottles of its HIV drug Truvada to the U.S. government’
Read More

New prostate cancer test could diagnose five years

Researchers at the University of East Anglia and the Norfolk and Norwich University Hospital have de
Read More

Is Bayer finally heading for a Roundup deal? Its n

Bayer has said it intends to “defend itself vigorously” in thousands of lawsuits that claim its Roun
Read More

Alexion’s Soliris gets new, and lucrative, rare di

Alexion’s rare disease drug Soliris has a new indication after the FDA approved it for a disease tha
Read More

Fred Hutch activates mandatory remote work policy

Fred Hutch announced it is activating a mandatory remote work policy as part of the center’s emerge
Read More


;